Inventor
Gregor Zlokarnik
Inventor
La Jolla, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C07DHeterocyclic compounds18%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests14%
A61KPreparations for medical, dental or toiletry purposes7%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
C07CAcyclic or carbocyclic compounds5%
C12NMicroorganisms or enzymes4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
PatentTitleYear
9,751,839'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20179,371,287'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20168,835,639'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20148,796,308'Modulators of cystic fibrosis transmembrane conductance regulator'20148,765,957'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20148,614,325'Modulators of cystic fibrosis transmembrane conductance regulator'20138,476,442'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20138,247,532'Deuterated hepatitis C protease inhibitors'20128,153,828'Optical molecular sensors for cytochrome P450 activity'20128,071,761'Substrates for beta-lactamase and uses thereof'20117,157,575'Substrates for β-lactamase and uses thereof'20077,132,252'Methods for detecting the interaction of compounds with cytochrome P450 using optical molecular sensors'20067,067,324'Photon reducing agents for fluorescence assays'20066,638,713'Optical molecular sensors for cytochrome P450 activity'20036,514,687'Optical molecular sensors for cytochrome P450 activity'20036,472,205'Cytosolic forms for -lactamase and uses thereof'20026,420,130'Optical molecular sensors for cytochrome P450 activity'20026,291,162'Cytosolic forms of beta-lactamase and uses thereof'20016,284,461'Use of inhibitors in reporter assays'20016,221,612'Photon reducing agents for use in fluorescence assays'20016,214,563'Photon reducing agents for reducing undesired light emission in assays'20016,200,762'Photon reducing agents and compositions for fluorescence assays'20016,143,492'Optical molecular sensors for cytochrome P450 activity'20006,031,094'Beta-lactam substrates and uses thereof'20005,955,604'Substrates for .beta.-lactamase and uses thereof'19995,741,657'Fluorogenic substrates for .beta.-lactamase and methods of use'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2011Patents assigned to UNIV CALIFORNIA (7)· patent assignee history
1998–2007Based in San Diego, CA, US· patent location history
2000–2003Patents assigned to AURORA BIOSCIENCES CORP (7)· patent assignee history
2000–2017Based in La Jolla, CA, US· patent location history
2006Patents assigned to INVITROGEN CORP (2)· patent assignee history
2011–2013Patents assigned to ZLOKARNIK GREGOR (5)· patent assignee history
2012–2017Patents assigned to VERTEX PHARMA (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 8 | 2012–2017 |
| AURORA BIOSCIENCES CORP | 7 | 2000–2003 |
| UNIV CALIFORNIA | 7 | 1998–2011 |
| ZLOKARNIK GREGORself | 5 | 2011–2013 |
| INVITROGEN CORP | 2 | 2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| La Jolla, California, US | 15 | 2000–2017 |
| San Diego, California, US | 11 | 1998–2007 |